EyePoint (EYPT) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed EyePoint (EYPT) over the past year, gaining 94.3% versus a loss of 74.9%. Over five years, EYPT leads with a -71.0% price change compared with -88.8% for PACB. Pacific Biosciences of California is the larger company by market cap ($704.0 million vs $287.2 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | PACB |
|---|---|---|
| Share price | $3.43 | $2.27 |
| Market cap | $287.16M | $704.03M |
| 1-day change | +3.16% | -16.73% |
| YTD return | -81.83% | +45.45% |
| 1-year return | -74.94% | +94.29% |
| 5-year return | -70.98% | -88.85% |
| EPS (TTM) | $-3.75 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $3.44 |
| 52-week low | $3.05 | $1.07 |
| Distance from 52-week high | -82.08% | -34.16% |
| Analyst consensus | none | buy |
| Avg. price target upside | +656.50% | -4.64% |
| Average volume | 3.93M | 10.10M |
| Shares outstanding | 83.84M | 310.83M |
| Employees | 214 | 485 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pacific Biosciences of California is about 2.5 times larger than EyePoint by market value ($704.03M vs $287.16M).
- PACB has outperformed EYPT by 169.2 percentage points over the past year.
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
EYPT vs PACB FAQ
Which is bigger, EyePoint or Pacific Biosciences of California?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $704.03M compared with $287.16M for EyePoint (EYPT).
Which stock has performed better over the past year, EYPT or PACB?
PACB returned +94.29% over the past 12 months, compared with -74.94% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Pacific Biosciences of California in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.